Moneycontrol Be a Pro
Get App
Last Updated : Jul 03, 2017 02:54 PM IST | Source: CNBC-TV18

Sequent Scientific gets CCI approval for Scheme of Arrangement

Competition Commission of India (CCI) approves Scheme of Arrangement between Strides Shasun, Sequent Scientific and Solara Active Pharma Sciences. In an interview to CNBC-TV18, Manish Gupta, CEO of Sequent Scientific spoke about the same.


Competition Commission of India (CCI) approves Scheme of Arrangement between Strides Shasun, Sequent Scientific and Solara Active Pharma Sciences.

In an interview to CNBC-TV18, Manish Gupta, CEO of Sequent Scientific spoke about the same.

“We have also filed for stock exchanges approvals which is imminent and thereafter we have to approach the National Company Law Tribunal (NCLT). We should initiate the process with NCLT by end of July,” he said.

He expects delays in the process and foresees about three months for the entire process to go through from NCLT perspective followed by the stock exchange which will be a couple of weeks exercise.

Close

Listing should occur by December or latest by January, he believes.

For full discussion, watch accompanying video...

Get access to India's fastest growing financial subscriptions service Moneycontrol Pro for as little as Rs 599 for first year. Use the code "GETPRO". Moneycontrol Pro offers you all the information you need for wealth creation including actionable investment ideas, independent research and insights & analysis For more information, check out the Moneycontrol website or mobile app.
First Published on Jul 3, 2017 02:26 pm

tags #Business

Loading...
Sections
Follow us on
Available On